Riskpilot← Back to searchSign inGet full accessKeraLase Klinik AB
ABActiveOrg 5592148166Malmövägen 12Beauty care and other beauty treatment activities · NACE 9622Est. 20191-4 employees
Revenue 2025
SEK 1,3M
+93% vs 2024
EBITDA margin
11.6%
+873% vs 2024
Equity ratio
15.4%
Financial strength
Net profit 2025
SEK 115K
+579% vs 2024
| Revenue | SEK 1,3M | +93% |
| EBITDA | SEK 155K | +873% |
| Net profit | SEK 115K | +579% |
| Total assets | SEK 1,1M | +603% |
| Equity | SEK 167K | +13% |
| Employees | — | — |
Legal name
KeraLase Klinik AB
Org number
5592148166
Legal form
Aktiebolag
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
14 augusti 2019
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva skönhetsverksamhet, innefattande skönhetsbehandlingar med laser, samt frisörverksamhet. Bolaget ska även hyra ut lasrar för skönhetsbehandlingar och lokaler för skönhets- och frisörverksamhet. Vidare ska bolaget bedriva friskvårdsbehandlingar samt sälja hårvårdsprodukter, hudvårdsprodukter och accessoarer för frisörer och barberare.
Address
Malmövägen 12
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 701 | 828 | 758 | 694 | 1 336 |
| Staff expenses | — | — | — | — | −0 |
| EBITDA | 14 | 59 | 1 | −20 | 155 |
| Depreciation & amort. | −23 | −10 | −7 | −5 | −19 |
| EBIT | −9 | 49 | −6 | −25 | 136 |
| Net financials | — | −2 | −1 | 1 | 0 |
| Profit before tax | −9 | 48 | −7 | −24 | 136 |
| Tax | −0 | −8 | −2 | −0 | −21 |
| Net profit | −9 | 40 | −9 | −24 | 115 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 165 | 177 | 174 | 155 | 1 089 |
| Equity | 142 | 181 | 172 | 148 | 167 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 23 | 5 | 2 | 7 | 922 |
| Total debt | 23 | 5 | 2 | 7 | 922 |
EBITDA margin
11.6%
This company
15.8%
Market median
-27% vs market
20212025
Equity ratio
15.4%
This company
38.2%
Market median
-60% vs market
20212025
Return on equity
68.7%
This company
18.4%
Market median
+273% vs market
20212025
Net profit margin
8.6%
This company
8.1%
Market median
+6% vs market
20212025
Asset turnover
1.23×
This company
1.12×
Market median
+10% vs market
20212025
Debt / equity
5.51×
This company
0.62×
Market median
-789% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Deputy Board Member | 2024 | |
| Former (2) | ||
| Board of Directors | 2022 – 2024 | |
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KeraLase Klinik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Milosz Kuberski | Board of Directors | 0 companies |
| Arkadiusz Swiacki | Deputy Board Member | 0 companies |
| Ciro Esposito | Board of Directors | 0 companies |
| Lisa Anna Siri Andersson | Deputy Board Member | 0 companies |